K2 PRINCIPAL FUND, L.P. - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 137 filers reported holding ITEOS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 2.26 and the average weighting 0.3%.

Quarter-by-quarter ownership
K2 PRINCIPAL FUND, L.P. ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$10,493,067
+1396.7%
707,080
+1275.6%
1.95%
+1512.4%
Q1 2024$701,09651,4000.12%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$29,989,69616.06%
MPM BioImpact LLC 1,745,943$19,118,0765.10%
Saturn V Capital Management LP 994,756$10,892,5784.56%
Boxer Capital, LLC 1,804,058$19,754,4351.05%
RA Capital Management 4,417,259$48,368,9860.95%
683 Capital Management, LLC 810,000$8,869,5000.69%
Ikarian Capital, LLC 346,471$3,793,8570.46%
Ikarian Capital, LLC 3,056$3,346,3200.40%
BVF INC/IL 1,259,476$13,791,2620.37%
DAFNA Capital Management LLC 98,560$1,079,2320.34%
View complete list of ITEOS THERAPEUTICS INC shareholders